Evidence map›Paper›PMID 38647373›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2024

Glycan-Reactive Innate-like B Cells and Developmental Checkpoints.

J Stewart New, Brian L P Dizon, John F Kearney, R Glenn King

Open access · greenAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.7field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Review
  2. Defining the Features of Complement-Active IgM.Journal of molecular biology · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

J Stewart NewDepartment of Microbiology, University of Alabama at Birmingham, Birmingham, AL.
Brian L P DizonDepartment of Microbiology, University of Alabama at Birmingham, Birmingham, AL.ORCID 0000-0002-2034-2353
John F KearneyDepartment of Microbiology, University of Alabama at Birmingham, Birmingham, AL.ORCID 0000-0003-2569-2560
R Glenn KingDepartment of Microbiology, University of Alabama at Birmingham, Birmingham, AL.ORCID 0000-0001-6522-0053
University of Alabama at Birmingham · US

Funding

XRAY CRYSTALLOGRAPHYP30CA013148 · NCI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI Robert S Welner · 1985 to 2026
$165.9M
Effects of neonatal microbial exposure on anti-polysaccharide B cell developmentU01AI100005 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI KEARNEY, JOHN FRANKLIN · 2017 to 2021
$1.9M
Effects of neonatal microbial exposure on anti-polysaccharide B cell developmentR01AI100005 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI KEARNEY, JOHN FRANKLIN · 2012 to 2016
$1.8M
REGULATION OF B CELL CLONAL DIVERSITYR21AI014782 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI KEARNEY, JOHN FRANKLIN · 2000 to 2000
$179k
Modulation of Autoimmune Diabetes by N-acetyl-D-glucosamine Specific B cellsF30DK082277 · NIDDK · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI DIZON, BRIAN LEONARD · 2008 to 2010
$99k
Commensal-dependent maturation of the natural IgM repertoireF31AI120500 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI NEW, JAMES STEWART · 2015 to 2017
$80k
HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID) R01AI4782HHS | NIH | NIAID | Division of Microbiology and Infectious Diseases (DMID) F30DK082277HHS | NIH | NIAID | Division of Microbiology and Infectious Diseases (DMID) F31AI120500NCI NIH HHS P30 CA013148NIAID NIH HHS F31 AI120500NIAID NIH HHS R01 AI100005NIAID NIH HHS R21 AI014782NIAID NIH HHS U01 AI100005NIDDK NIH HHS F30 DK082277
6 · The paper itself

Abstract

Using an Ig H chain conferring specificity for N-acetyl-d-glucosamine (GlcNAc), we developed transgenic (VHHGAC39 TG) mice to study the role of self-antigens in GlcNAc-reactive B-1 B cell development. In VHHGAC39 TG mice, GlcNAc-reactive B-1 B cell development during ontogeny and in adult bone marrow was normal. However, adult TG mice exhibited a block at transitional-2 immature B cell stages, resulting in impaired allelic exclusion and accumulation of a B cell subset coexpressing endogenous Ig gene rearrangements. Similarly, VHHGAC39 B cell fitness was impeded compared with non-self-reactive VHJ558 B TG cells in competitive mixed bone marrow chimeras. Nonetheless, adult VHHGAC39 mice immunized with Streptococcus pyogenes produce anti-GlcNAc Abs. Peritoneal cavity B cells transferred from VHHGAC39 TG mice into RAG-/- mice also exhibited robust expansion and anti-GlcNAc Ab production. However, chronic treatment of young VHHGAC39 mice with GlcNAc-specific mAbs leads to lower GlcNAc-binding B cell frequencies while increasing the proportion of GlcNAc-binding B1-a cells, suggesting that Ag masking or clearance of GlcNAc Ags impedes maturation of newly formed GlcNAc-reactive B cells. Finally, BCR H chain editing promotes expression of endogenous nontransgenic BCR alleles, allowing potentially self-reactive TG B cells to escape anergy or deletion at the transitional stage of precursor B cell development. Collectively, these observations indicate that GlcNAc-reactive B cell development is sensitive to the access of autologous Ags.

Indexed as

AcetylglucosamineMice, TransgenicAnimalsAutoantigensB-LymphocytesB-Lymphocyte SubsetsCell DifferentiationImmunity, InnateImmunoglobulin Heavy ChainsMiceMice, Inbred C57BLStreptococcus pyogenesAcetylglucosamineAutoantigensImmunoglobulin Heavy Chains

Identifiers

PMID38647373
PMCPMC11147723
OpenAlexW4394999580

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.